Pasar al contenido principal

VESICULAS EXTRACELULARES E INMUNOTERAPIA FRENTE AL CANCER

PID2023-149514OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genome-Wide CRISPR/Cas9 Screening Identifies the COMMANDER Recycling Complex as a Key Player in EV Uptake

  • Palma-Cobo, Miguel
  • Toribio, Victor
  • Morales, Joaquín
  • López-Martín, Soraya
  • Enrich, Carlos
  • Lu, Albert
  • Yáñez-Mó, María
Extracellular vesicles (EVs) hold immense potential in therapeutic delivery, warranting a comprehensive investigation of the mechanisms that regulate their uptake by target cells. To identify key molecular regulators of EV internalization, we conducted a genome-wide CRISPR (GWC) screen aimed to pinpoint candidate genes that influence EV uptake. We employed a GWC library spanning the entire human genome in K562 cells. 3.6 × 10 EVs isolated from the SKMEL147 human melanoma cell line were labelled with Alexa633-C5-Maleimide and incubated for 2 h with 500 × 10⁶ K562 cells, providing a 2000× coverage of the library. The top 5% of high and low fluorescence populations were sorted. Next-generation sequencing (NGS) was performed to quantify sgRNA enrichment in the sorted populations compared to the unsorted control. Remarkably, among other genes, several members of the COMMANDER complex emerged as significant hits in our screen. We validated the hits in knockout (KO) cell lines of both K562 and HeLa cells using EVs derived either from melanoma or breast cancer cell lines. Kinetic follow-up of EV cargo, including surface or luminal proteins, suggests that the COMMANDER complex plays a pivotal role in the early stages of EV uptake but also in the final fate of EV components in the target cell., This work has been supported by grants PID2020-119627GB-I00, DTS21/00134, and PID2023-149514OB-I00 from Ministerio Español de Ciencia e Innovación (Spain) to MY-M. A.L. is supported by a grant from the Spanish Ministerio de Ciencia e Innovación (PID2022-138728OB-I00). V.T. was supported byan FPI-UAM fellowship and a GEIVEX mobility Fellowship,. and M.P. by a predoctoral contract from Comunidad de Madrid (PIPF-2023/SAL-GL-29726)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extracellular vesicle-inspired liposomes boost immune response against pathogen antigens

  • Morales, Joaquín
  • Gutiérrez Del Burgo, Fernando
  • Benayas, Beatriz
  • Palma-Cobo, Miguel
  • Toribio, Víctor
  • Martín-Moreno, Alejandro
  • Lacruz-Pleguezuelos, Blanca
  • López-Martín, Soraya
  • Casasnovas, José María
  • Staufer, Oskar
  • Soto, Manuel
  • Yáñez-Mó, María
Developing effective vaccines against some diseases remains a global health priority. However, targeting immunity against a specific disease-related antigen requires efficient adjuvant systems that adequately promote vaccination efficacy. Extracellular vesicles have been identified as a potential adjuvant platform technology but are still limited in their reproducibility and safety. Here, we present a synthetic extracellular vesicle mimetic (EVM) platform that enhances antigen immunogenicity by incorporating the large extracellular loop (LEL) of the tetraspanin CD9, a protein abundant on natural extracellular vesicles. Liposomes with defined lipid composition were functionalized with recombinant CD9-LEL and pathogen antigens-KMP-11 from Leishmania and the SARS-CoV-2 Spike (S) protein. BALB/c mice were immunized intraperitoneally with nanovesicles carrying CD9-LEL, the pathogen antigens alone, or both. Antigen-specific IgG responses were measured by ELISA, and vesicle uptake by immune cells was assessed via flow cytometry. CD9-LEL alone did not elicit an immune response, but its co-presentation with antigens significantly enhanced specific anti-pathogen IgG titers. Notably, KMP-11 alone failed to induce detectable antibodies, while nanovesicles carrying both CD9-LEL and KMP-11 triggered strong IgG1 and IgG2b responses. Similarly, nCD9 + S induced higher IgG titers than S alone. CD9-LEL promoted uptake of nanovesicles by peritoneal macrophages, suggesting improved antigen presentation. Combining EVMs with classical adjuvants further modulated the immune profile: alum favored IgG1 (Th2 bias), while CpG ODNs enhanced IgG2a and IgG2b (Th1 bias), crucial for intracellular pathogen clearance. The platform demonstrated safety and adaptability. In conclusion, CD9-LEL-decorated EVMs represent a promising, scalable vaccine strategy capable of boosting antigen immunogenicity and directing immune polarization, offering a versatile tool for combating challenging or emergent infectious diseases., his work has been supported by grants PID2020-119627GB-I00, PDC2021-121052 and PID2023-149514OB-I00 funded by MICIU/AEI /10.13039/501100011033 and by FEDER/UE to MY-M. JM was supported by PEJ-2023-AI_SAL-GL-26725 contract and GEIVEX MOVE fellowship, BB by a graduate industrial contract IND2019_BMD-17100 and GEIVEX mobility fellowship, and MP-C by a predoctoral contract PIPF-2023/SAL-GL- 29726, all from Comunidad de Madrid; VT was supported by a FPI-UAM fellowship. JMC was Supported by the Spanish Research Council (CSIC) and Ministry of Science, Innovation and Universities (MICIU) grant PIE-RD-COVID 19 (202020E079) and by the PTI+ Salud Global and NextGeneration EU grant SGL 2103047. The Centro de Biología Molecular Severo Ochoa is the recipient of a ‘Severo Ochoa Excellence’ grant (CEX2021-001154-S) funded by MICIU/AEI/10.13039/501100011033 and receives institutional support from the Ramón Areces Foundation., Peer reviewed, Modelo experimental alternativo-NAM, Organismos alternativos no vertebrados - Microorganismos Unicelulares